Alzheimer’s disease (AD) is characterized by memory loss and executive dysfunction, which correspond to structural changes to the medial temporal lobes (MTL) and prefrontal cortex (PFC), respectively. Given the overlap in cognitive deficits between healthy aging and the earliest stages of AD, early detection of AD remains a challenge. The goal of the present study was to study MTL- and PFC-dependent cognitive functioning in middle-aged individuals at genetic risk for AD or cognitive impairment who do not currently manifest any clinical symptoms. Participants (N = 150; aged 40–60 years) underwent genotyping of 47 single nucleotide polymorphisms (SNPs) in six genes previously associated with memory or executive functioning: APOE, SORL1, BDNF, TOMM40, KIBRA, and COMT. They completed two MTL-dependent tasks, the virtual Morris Water Task (vMWT) and transverse patterning discriminations task (TPDT), and the PFC-dependent reversal learning task. Although age was associated with poorer performance on the vMWT and TPDT within this middle-aged sample, there were no genotype-associated differences in cognitive performance. Although the vMWT and TPDT may be sensitive to age-related changes in cognition, carriers of APOE, SORL1, BDNF, TOMM40, KIBRA, and COMT risk alleles do not exhibit alteration in MTL- and PFC-dependent functioning in middle age compared to non-carriers.
Alzheimer’s Association
(2015) 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 11, 332–384.
2.
CummingsJL, MorstorfT, ZhongK (2014) Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures. Alzheimers Res Ther. 6, 37.
3.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCR, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269.
4.
GreenwoodPM, LambertC, SunderlandT, ParasuramanR (2005) Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results From the National Institute of Mental Health’s BIOCARD study. Neuropsychology. 19, 199–211.
5.
McDonaldCR, McEvoyLK, GharapetianL, Fennema-NotestineC, HaglerDJ, HollandD, KoyamaA, BrewerJB, DaleAM, (2009) Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology. 73, 457–465 Alzheimer’s Disease Neuroimaging Initiative.
MiyakeA, FriedmanNP, EmersonMJ, WitzkiAH, HowerterA, WagerTD (2000) The unity and diversity of executive functions and their contributions to complex “Frontal Lobe” tasks: A latent variable analysis. Cogn Psychol. 41, 49–100.
8.
ApostolovaLG, DuttonRA, DinovID, HayashiKM, TogaAW, CummingsJL, ThompsonPM (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol. 63, 693–699.
9.
DrzezgaA, LautenschlagerN, SiebnerH, RiemenschneiderM, WillochF, MinoshimaS, SchwaigerM, KurzA (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: A PET follow-up study. Eur J Nucl Med Mol Imaging. 30, 1104–1113.
10.
FarrerLA, CupplesLA, HainesJL, HymanB, KukullWA, MayeuxR, MyersRH, Pericak-VanceMA, RischN, van DuijnCM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA. 278, 1349–1356.
11.
BertramL, McQueenMB, MullinK, BlackerD, TanziRE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet. 39, 17–23.
12.
WisdomNM, CallahanJL, HawkinsKA (2011) The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiol Aging. 32, 63–74.
13.
Elias-SonnenscheinLS, ViechtbauerW, RamakersIH, VerheyFR, VisserPJ (2011) Predictive value of APOE-ɛ4 allele for progression from MCI to AD-type dementia: A meta-analysis. J Neurol Neurosurg Psychiatry. 82, 1149–1156.
14.
KölschH, JessenF, WiltfangJ, LewczukP, DichgansM, KornhuberJ, FrölichL, HeuserI, PetersO, SchulzJB, SchwabSG, MaierW (2008) Influence of SORL1 gene variants: Association with CSF amyloid-beta products in probable Alzheimer’s disease. Neurosci Lett. 440, 68–71.
15.
OffeK, DodsonSE, ShoemakerJT, FritzJJ, GearingM, LeveyAI, LahJJ (2006) The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci. 26, 1596–1603.
HoulihanLM, HarrisSE, LucianoM, GowAJ, StarrJM, VisscherPM, DearyIJ (2009) Replication study of candidate genes for cognitive abilities: The Lothian Birth Cohort 1936. Genes Brain Behav. 8, 238–247.
18.
BraltenJ, Arias-VásquezA, MakkinjeR, VeltmanJA, BrunnerHG, FernándezG, RijpkemaM, FrankeB (2011) Association of the Alzheimer’s gene SORL1 with hippocampal volume in young, healthy adults. Am J Psychiatry. 168, 1083–1089.
19.
AssarehAA, PiguetO, LyeTC, MatherKA, BroeGA, SchofieldPR, SachdevPS, KwokJB (2014) Association of SORL1 gene variants with hippocampal and cerebral atrophy and Alzheimer’s disease. Curr Alzheimer Res. 11, 558–563.
MurerMG, BoissiereF, YanQ, HunotS, VillaresJ, FaucheuxB, AgidY, HirschE, Raisman-VozariR (1999) An immunohistochemical study of the distribution of brain- derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer’s disease. Neuroscience. 88, 1015–1032.
VoineskosAN, LerchJP, FelskyD, ShaikhS, RajjiTK, MirandaD, LobaughNJ, MulsantBH, PollockBG, KennedyJL (2011) The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry. 68, 198–206.
25.
FerenczB1, KarlssonS, KalpouzosG (2012) Promising genetic biomarkers of preclinical Alzheimer’s disease: The influence of APOE and TOMM40 on brain integrity. Int J Alzheimers Dis. 2012, 421452.
26.
JohannsenS, DuningK, PavenstädtH, KremerskothenJ, BoeckersTM (2008) Temporal-spatial expression and novel biochemical properties of the memory-related protein KIBRA. Neuroscience. 155, 1165–1173.
27.
PapassotiropoulosA, StephanDA, HuentelmanMJ, HoerndliFJ, CraigDW, PearsonJV, HuynhKD, BrunnerF, CorneveauxJ, OsborneD, WollmerMA, AerniA, ColucciaD, HänggiJ, MondadoriCR, BuchmannA, ReimanEM, CaselliRJ, HenkeK, deDJ, Quervain (2006) Common Kibra alleles are associated with human memory performance. Science. 314, 475–478.
28.
BatesTC, PriceJF, HarrisSE, MarioniRE, FowkesFG, StewartMC, MurrayGD, WhalleyLJ, StarrJM, DearyIJ (2009) Association of KIBRA and memory. Neurosci Lett. 458, 140–143.
29.
WitteAV, KöbeT, KertiL, RujescuD, FlöelA (2016) Impact of KIBRA polymorphism on memory function and the hippocampus in older adults. Neuropsychopharmacology. 41, 781–790.
30.
CorneveauxJJ, LiangWS, ReimanEM, WebsterJA, MyersAJ, ZismannVL, JoshipuraKD, PearsonJV, Hu-LinceD, CraigDW, CoonKD, DunckleyT, BandyD, LeeW, ChenK, BeachTG, MastroeniD, GroverA, RavidR, SandoSB, AaslyJO, HeunR, JessenF, KölschH, RogersJ, HuttonML, MelquistS, PetersenRC, AlexanderGE, CaselliRJ, PapassotiropoulosA, StephanDA, HuentelmanMJ (2010) Evidence for an association between KIBRA and late-onset Alzheimer’s disease. Neurobiol Aging. 31, 901–909.
31.
ChenJ, LipskaBK, HalimN, MaQD, MatsumotoM, MelhemS, KolachanaBS, HydeTM, HermanMM, ApudJ, EganMF, KleinmanJE, WeinbergerDR (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75, 807–821.
32.
BarnettJH, JonesPB, RobbinsTW, MüllerU (2007) Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry. 12, 502–509.
33.
WishartHA, RothRM, SaykinAJ, RhodesCH, TsongalisGJ, PattinKA, MooreJH, McAllisterTW (2011) COMT Val158Met genotype and individual differences in executive function in healthy adults. J Int Neuropsychol Soc. 17, 174–180.
34.
PapenbergG, BäckmanL, NagelIE, NietfeldW, SchröderJ, BertramL, HeekerenHR, LindenbergerU, LiSC (2014) COMT polymorphism and memory dedifferentiation in old age. Psychol Aging. 29, 374–383.
35.
de FriasCM, AnnerbrinkK, WestbergL, ErikssonE, AdolfssonR, NilssonLG (2004) COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet. 34, 533–539.
36.
TuminelloER, HanSD (2011) The apolipoprotein E antagonistic pleiotropy hypothesis: Review and recommendations. Int J Alzheimers Dis. 2011, 726197.
37.
LowndesG, SavageG (2007) Early detection of memory impairment in Alzheimer’s disease: A neurocognitive perspective on assessment. Neuropsychol Rev. 17, 193–202.
38.
SagerMA, HermannB, La RueA (2005) Middle-aged children of persons with Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer’s Prevention. J Geriatr Psychiatry Neurol. 18, 245–249.
39.
GreenwoodPM, EspesethT, LinMK, ReinvangI, ParasuramanR (2014) Longitudinal change in working memory as a function of APOE genotype in midlife and old age. Scand J Psychol. 55, 268–277.
40.
ReimanEM, CaselliRJ, YunLS, ChenK, BandyD, MinoshimaS, ThibodeauSN, OsborneD (1996) Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 334, 752–758.
41.
AsturRS, OrtizML, SutherlandRJ (1998) A characterization of performance by men and women in a virtual Morris water task: A large and reliable sex difference. Behav Brain Res. 93, 185–190.
42.
MorrisRG, GarrudP, RawlinsJN, O’KeefeJ (1982) Place ngation impaired in rats with hippocampal lesions. Nature. 297, 681–683.
43.
AsturRS, TaylorLB, MamelakAN, PhilpottL, SutherlandRJ (2002) Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav Brain Res. 132, 77–84.
DriscollI, HamiltonDA, PetropoulosH, YeoRA, BrooksWM, BaumgartnerRN, SutherlandRJ (2003) The aging hippocampus: Cognitive, biochemical and structural findings. Cereb Cortex. 13, 1344–1351.
46.
MoffatSD, ElkinsW, ResnickSM (2006) Age differences in the neural systems supporting human allocentric spatial ngation. Neurobiol Aging. 27, 965–972.
47.
SpenceKW (1952) The nature of the response in discrimination learning. Psychol Rev. 59, 89–93.
48.
AlvaradoMC, RudyJW (1992) Some properties of configural learning: An investigation of the transverse-patterning problem. J Exp Psychol Anim Behav Process. 18, 145–153.
49.
ReedJM, SquireLR (1999) Impaired transverse patterning in human amnesia is a special case of impaired memory for two-choice discrimination tasks. Behav Neurosci. 113, 3–9.
50.
RickardTC, GrafmanJ (1998) Losing their configural mind. Amnesic patients fail on transverse patterning. J Cogn Neurosci. 10, 509–524.
51.
AlvaradoMC, BachevalierJ (2005) Comon of the effects of damage to the perirhinal and parahippocampal cortex on transverse patterning and location memory in rhesus macaques. J Neurosci. 25, 1599–1609.
52.
OstreicherML, MosesSN, RosenbaumRS, RyanJD (2010) Prior experience supports new learning of relations in aging. J Gerontol B Psychol Sci Soc Sci. 65, 32–41.
53.
HornakJ, O’DohertyJ, BramhamJ, RollsET, MorrisRG, BullockPR, PolkeyCE (2004) Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci. 16, 463–478.
McAlonanK, BrownVJ (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res. 146, 97–103.
56.
BoulougourisV, DalleyJW, RobbinsTW (2007) Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res. 179, 219–228.
57.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12, 189–198.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 17, 37–49.
60.
MoffatSD, ResnickSM (2002) Effects of age on virtual environment place ngation and allocentric cognitive mapping. Behav Neurosci. 116, 851–859.
61.
DriscollI, HamiltonDA, YeoRA, BrooksWM, SutherlandRJ (2005) Virtual ngation in humans: The impact of age, sex, and hormones on place learning. Horm Behav. 47, 326–335.
62.
CaselliRJ, ReimanEM, OsborneD, HentzJG, BaxterLC, HernandezJL, AlexanderGG (2004) Longitudinal changes in cognition and behor in asymptomatic carriers of the APOE e4 allele. Neurology. 62, 1990–1995.
63.
BlairCK1, FolsomAR, KnopmanDS, BrayMS, MosleyTH, BoerwinkleE (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology. 64, 268–276 Atherosclerosis Risk in Communities (ARIC) Study Investigators.
64.
HanSD, DrakeAI, CessanteLM, JakAJ, HoustonWS, DelisDC, FiloteoJV, BondiMW (2007) Apolipoprotein E and traumatic brain injury in a military population: Evidence of a neuropsychological compensatory mechanism?J Neurol Neurosurg Psychiatry. 78, 1103–1108.
65.
SeshadriS, DeStefanoAL, AuR, MassaroJM, BeiserAS, Kelly-HayesM, KaseCS, D’AgostinoRB, DecarliC, AtwoodLD, WolfPA (2007) Genetic correlates of brain aging on MRI and cognitive test measures: A genome-wide association and linkage analysis in the Framingham Study.S. BMC Med Genet. 8, 15.
66.
EganMF, KojimaM, CallicottJH, GoldbergTE, KolachanaBS, BertolinoA, ZaitsevE, GoldB, GoldmanD, DeanM, LuB, WeinbergerDR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112, 257–269.
67.
EganMF, GoldbergTE, KolachanaBS, CallicottJH, MazzantiCM, StraubRE, GoldmanD, WeinbergerDR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 98, 6917–6922.
68.
JooberR, GauthierJ, LalS, BloomD, LalondeP, RouleauG, BenkelfatC, LabelleA (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 59, 662–663.
69.
MalhotraAK, KestlerLJ, MazzantiC, BatesJA, GoldbergT, GoldmanD (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 159, 652–654.
70.
GoldbergTE, EganMF, GscheidleT, CoppolaR, WeickertT, KolachanaBS, GoldmanD, WeinbergerDR (2003) Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry. 60, 889–896.
71.
BarnettJH, ScorielsL, MunafòMR (2008) Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 64, 137–144.
72.
BruderGE, KeilpJG, XuH, ShikhmanM, SchoriE, GormanJM, GilliamTC (2005) Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol Psychiatry. 58, 901–907.
73.
MacDonaldAW, CarterCS, FloryJD, FerrellRE, ManuckSB (2007) COMT val158Met and executive control: A test of the benefit of specific deficits to translational research. J Abnorm Psychol. 116, 306–312.
74.
TsaiSJ, YuYW, ChenTJ, ChenJY, LiouYJ, ChenMC, HongCJ (2003) Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett. 338, 123–126.
75.
O’HaraR, MillerE, LiaoCP, WayN, LinX, HallmayerJ (2006) COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci Lett. 409, 205–209.
76.
HoBC, MilevP, O’LearyDS, LibrantA, AndreasenNC, WassinkTH (2006) Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry. 63, 731–740.
77.
HarrisSE, FoxH, WrightAF, HaywardC, StarrJM, WhalleyLJ, DearyIJ (2006) The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry. 11, 505–513.
78.
VentrigliaM, Bocchio ChiavettoL, BenussiL, BinettiG, ZanettiO, RivaMA, GennarelliM (2002) Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Mol Psychiatry. 7, 136–137.
79.
EricksonKI, KimJS, SueverBL, VossMW, FrancisBM, KramerAF (2008) Genetic contributions to age-related decline in executive function: A 10-year longitudinal study of COMT and BDNF polymorphisms. Front Hum Neurosci. 2, 11.
80.
LindenbergerU, NagelIE, ChicherioC, LiSC, HeekerenHR, BäckmanL (2008) Age-related decline in brain resources modulates genetic effects on cognitive functioning. Front Neurosci. 2, 234–244.
81.
SasAA, SniederH, KorfJ (2012) Gompertz’ survivorship law as an intrinsic principle of aging. Med Hypotheses. 78, 659–663.
82.
RazN, LindenbergerU, RodrigueKM, KennedyKM, HeadD, WilliamsonA, DahleC, GerstorfD, AckerJD (2005) Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cereb Cortex. 15, 1676–1689.
83.
GannonM, CheP, ChenY, JiaoK, RobersonED, WangQ (2015) Noradrenergic dysfunction in Alzheimer’s disease. Front Neurosci. 9, 220.
84.
RodriguezJJ, NoristaniHN, VerkhratskyA (2012) The serotonergic system in ageing and Alzheimer’s disease. Prog Neurobiol. 99, 15–41.
